Media Thread, page-15769

Yes i think you are right in saying each to their own. But i beg to differ from a popular misconception on this forum that IMU will be a $ one day...... i dont think the current team neither board nor management are visionary (in terms of nurturing a company to greater heights and staying put for a very long-term like a CSL or even PME). 1$ translates into 8 billion Mcap considering no further dilution. That's huge feet to achieve. I sincerely hope the team proves me wrong but I doubt it big time.

At every opportunity leslie and Paul get they make it very evidently clear they want to sell IMU assets out (a visionary builds on assets). They talk about take overs, buy outs and not looking to manufacture drug and distributing and so on..... Iam not saying its good or bad........ it makes me chuckle wen ppl talk $'s with IMU.

People who build a company and make it a conglomerate are of different breed...... I would be extremely and pleasantly surprised if Imu can hit a ATH. I see the company would prep to sell out much before that........

What do I know except to taper my expectations down and try to be a realist....... some might say even with these expectations iam still dreaming (especially our neighbours who visit often on our threads). To them I say may be you are right atleast it is an achievable dream.

If the 3 cylinders IMU is working on fires and are on track to achieve their logical end with good safety and efficacy. IMU can achieve 2 billion Mcap. Roughly 25c....This is where big pharmaceuticals can find IMU completely derisked and lucrative ........ This is where i review my investment. Just look around on asx for a biotech crossing 2 or 3 billion mark is a huge hurdle.

Please do your own research
Spidey